Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$131.40
-1.7%
$130.41
$110.86
$141.23
$228.70B0.696.65 million shs2.55 million shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$787.29
+0.9%
$728.85
$439.38
$793.17
$238.33B1.412.46 million shs1.01 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$156.60
+0.1%
$145.30
$94.33
$158.48
$249.99B1.336.47 million shs4.03 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.76%+1.72%-0.05%+15.05%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+5.65%+6.90%+24.41%+63.02%
Morgan Stanley stock logo
MS
Morgan Stanley
0.00%+5.56%+8.25%+19.56%+59.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$131.40
-1.7%
$130.41
$110.86
$141.23
$228.70B0.696.65 million shs2.55 million shs
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$787.29
+0.9%
$728.85
$439.38
$793.17
$238.33B1.412.46 million shs1.01 million shs
Morgan Stanley stock logo
MS
Morgan Stanley
$156.60
+0.1%
$145.30
$94.33
$158.48
$249.99B1.336.47 million shs4.03 million shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.76%+1.72%-0.05%+15.05%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+5.65%+6.90%+24.41%+63.02%
Morgan Stanley stock logo
MS
Morgan Stanley
0.00%+5.56%+8.25%+19.56%+59.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.91
Moderate Buy$144.479.95% Upside
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.33
Hold$660.00-16.17% Downside
Morgan Stanley stock logo
MS
Morgan Stanley
2.47
Hold$138.25-11.72% Downside

Current Analyst Ratings Breakdown

Latest MS, ABT, and GS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/15/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
7/21/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$550.00 ➝ $700.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$147.00 ➝ $142.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$142.00 ➝ $141.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$148.00 ➝ $145.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldBuy$143.00 ➝ $145.00
7/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
7/17/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetMarket Perform$771.00 ➝ $790.00
7/17/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$680.00 ➝ $715.00
7/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$130.00 ➝ $140.00
7/15/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$145.00 ➝ $147.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.45$6.47 per share20.31$27.62 per share4.76
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$126.85B1.88$54.18 per share14.53$350.27 per share2.25
Morgan Stanley stock logo
MS
Morgan Stanley
$107.29B2.33$11.53 per share13.58$59.39 per share2.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.9816.4722.932.5432.43%18.32%10.71%10/15/2025 (Estimated)
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$14.28B$45.3817.3515.121.6412.37%14.32%0.89%10/14/2025 (Estimated)
Morgan Stanley stock logo
MS
Morgan Stanley
$13.39B$8.8317.7416.611.9413.06%15.20%1.15%10/15/2025 (Estimated)

Latest MS, ABT, and GS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.26$1.26N/A$1.01$11.01 billion$11.14 billion
7/16/2025Q2 2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$9.82$10.91+$1.09$10.91$13.53 billion$14.58 billion
7/16/2025Q2 2025
Morgan Stanley stock logo
MS
Morgan Stanley
$1.98$2.13+$0.15$2.13$16.15 billion$16.79 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.80%N/A29.57%54 Years
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$16.002.03%N/A35.26%13 Years
Morgan Stanley stock logo
MS
Morgan Stanley
$4.002.55%N/A45.30%12 Years

Latest MS, ABT, and GS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/14/2025
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$4.002.15%8/29/20258/29/20259/29/2025
7/16/2025
Morgan Stanley stock logo
MS
Morgan Stanley
quarterly$1.002.6%7/31/20257/31/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.25
1.82
1.30
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.57
0.67
0.67
Morgan Stanley stock logo
MS
Morgan Stanley
3.30
0.78
0.78

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Morgan Stanley stock logo
MS
Morgan Stanley
84.19%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Morgan Stanley stock logo
MS
Morgan Stanley
0.19%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
46,500302.72 million301.06 millionOptionable
Morgan Stanley stock logo
MS
Morgan Stanley
80,0001.60 billion1.59 billionOptionable

Recent News About These Companies

$SNOW stock is up 2% today. Here's what we see in our data.
$LRN stock is down 8% today. Here's what we see in our data.
New Analyst Forecast: $PLNT Given 'Buy' Rating
New Analyst Forecast: $SPG Given 'In-Line' Rating
New Analyst Forecast: $AXP Given 'Buy' Rating
New Analyst Forecast: $PANW Given 'Outperform' Rating
New Analyst Forecast: $AMH Given 'Outperform' Rating
New Analyst Forecast: $MDB Given 'Outperform' Rating
New Analyst Forecast: $ARGX Given 'Buy' Rating
New Analyst Forecast: $AR Given 'Buy' Rating
New Analyst Forecast: $CPT Given 'In-Line' Rating
New Analyst Forecast: $WEN Given 'Neutral' Rating
Morgan Stanley $MS Shares Sold by LVM Capital Management Ltd. MI

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$131.40 -2.33 (-1.74%)
Closing price 03:59 PM Eastern
Extended Trading
$130.86 -0.54 (-0.41%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$787.29 +7.23 (+0.93%)
Closing price 03:59 PM Eastern
Extended Trading
$786.93 -0.36 (-0.05%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Morgan Stanley stock logo

Morgan Stanley NYSE:MS

$156.60 +0.21 (+0.14%)
Closing price 03:59 PM Eastern
Extended Trading
$156.64 +0.03 (+0.02%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.